Revolutionary gene therapy may offer new life for patients battling chronic sickle cell disease

The University of Chicago is one of nine medical centers initially approved to offer the therapy, with the University of Illinois at Chicago expected to do so early in 2024.

Related Keywords

India ,University Of Chicago ,Illinois ,United States ,Rush University Medical Center ,University Of Illinois At Chicago ,Chicago ,Americans ,Nicole Verdun ,James Labelle ,Damiano Rondelli ,Cellular Therapy Program ,Chicago Tribune ,Novartis ,University Of Chicago Medicine ,Vertex Pharmaceuticals Inc ,Drug Administration ,Lyric Porter ,Chicago Medicine ,Pediatric Stem Cell ,University Medical Center ,Middle East ,